23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
102.97%
Revenue growth exceeding 1.5x Insurance - Life median of 0.96%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
102.97%
Positive gross profit growth while Insurance - Life median is negative. Peter Lynch would see a notable competitive edge in cost or pricing.
-57.44%
Negative EBIT growth while Insurance - Life median is -72.40%. Seth Klarman would check if external or internal factors caused the decline.
-66.92%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-66.94%
Negative net income growth while Insurance - Life median is -25.65%. Seth Klarman would investigate factors dragging net income down.
-63.76%
Negative EPS growth while Insurance - Life median is -45.08%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-63.76%
Negative diluted EPS growth while Insurance - Life median is -44.79%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.38%
Dividend growth under 50% of Insurance - Life median of 4.00%. Jim Chanos would suspect the firm’s cash flow can’t keep pace with peers.
-6.17%
Negative OCF growth while Insurance - Life median is -6.17%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-6.17%
Negative FCF growth while Insurance - Life median is -6.17%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-24.30%
Negative 10Y revenue/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
-40.60%
Negative 5Y CAGR while Insurance - Life median is -49.46%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
389.40%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 1.19%. Joel Greenblatt might see a short-term competitive advantage at play.
223.72%
Positive 10Y OCF/share CAGR while Insurance - Life median is negative. Peter Lynch might see a notable advantage in stable or growing cash flows.
40.24%
OCF/share CAGR of 40.24% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
167.10%
3Y OCF/share growth > 1.5x Insurance - Life median of 29.33%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
-20.99%
Negative 10Y net income/share CAGR vs. Insurance - Life median of -48.36%. Seth Klarman might see a fundamental problem if peers maintain growth.
-51.57%
Negative 5Y CAGR while Insurance - Life median is -45.38%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
145.85%
Positive 3Y CAGR while Insurance - Life median is negative. Peter Lynch sees a big short-term advantage vs. peers struggling with profit declines.
32.96%
Positive 10Y equity/share growth while Insurance - Life median is negative. Peter Lynch sees a significant edge in building book value vs. struggling peers.
-5.68%
Negative 5Y equity/share growth while Insurance - Life median is -9.15%. Seth Klarman suspects firm-specific weaknesses if peers grow equity mid-term.
-5.31%
Negative 3Y equity/share growth while Insurance - Life median is -27.90%. Seth Klarman sees a short-term weakness if peers still expand net worth.
139.40%
Dividend/share CAGR exceeding 1.5x Insurance - Life median of 69.53% over 10 years. Joel Greenblatt sees a standout distribution growth track, assuming sustainability.
37.56%
5Y dividend/share CAGR near Insurance - Life median. Charlie Munger sees a typical sector-level payout approach mid-term.
16.03%
3Y dividend/share growth 1.25-1.5x Insurance - Life median. Mohnish Pabrai checks if coverage remains safe in the near term.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.27%
Asset growth near Insurance - Life median. Charlie Munger attributes it to a typical industry cycle of capital investment.
0.39%
Below 50% of Insurance - Life median. Jim Chanos suspects deeper issues blocking net worth accumulation.
0.11%
Slightly rising debt while Insurance - Life median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
No Data
No Data available this quarter, please select a different quarter.
-9.49%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.